David Linetsky Sells 11,853 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) SVP David Linetsky sold 11,853 shares of the company's stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $24.85, for a total value of $294,547.05. Following the transaction, the senior vice president now directly owns 188,354 shares in the company, valued at approximately $4,680,596.90. The trade was a 5.92 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link.

David Linetsky also recently made the following trade(s):

• On Friday, October 18th, David Linetsky sold 1,100 shares of Phreesia stock. The stock was sold at an average price of $20.49, for a total value of $22,539.00.
• On Tuesday, October 15th, David Linetsky sold 2,011 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total transaction of $42,291.33.
• On Thursday, September 19th, David Linetsky sold 24 shares of Phreesia stock. The shares were sold at an average price of $24.04, for a total value of $576.96.
• On Tuesday, September 17th, David Linetsky sold 36 shares of Phreesia stock. The stock was sold at an average price of $24.77, for a total transaction of $891.72.

Phreesia Price Performance

NYSE PHR traded up $0.39 on Friday, hitting $24.94. The company had a trading volume of 532,812 shares, compared to its average volume of 450,490. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. The company has a market capitalization of $1.45 billion, a PE ratio of -16.70 and a beta of 0.98. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $29.16. The company's fifty day moving average price is $20.39 and its 200-day moving average price is $21.80.

Phreesia (NYSE:PHR - Get Free Report) last released its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business's quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter last year, the business posted ($0.58) earnings per share. As a group, analysts predict that Phreesia, Inc. will post -1.22 earnings per share for the current year.

Institutional Investors Weigh In On Phreesia

A number of hedge funds have recently modified their holdings of the business. International Assets Investment Management LLC boosted its position in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock worth $33,000 after acquiring an additional 1,395 shares during the last quarter. nVerses Capital LLC boosted its holdings in shares of Phreesia by 76.5% during the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company's stock worth $64,000 after purchasing an additional 1,300 shares during the last quarter. Lombard Odier Asset Management USA Corp purchased a new stake in shares of Phreesia in the second quarter valued at approximately $202,000. Point72 DIFC Ltd purchased a new stake in shares of Phreesia in the second quarter valued at approximately $209,000. Finally, XTX Topco Ltd acquired a new stake in shares of Phreesia in the third quarter valued at approximately $247,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Truist Financial increased their price target on Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a research report on Wednesday. Needham & Company LLC reaffirmed a "buy" rating and set a $29.00 target price on shares of Phreesia in a report on Tuesday. Royal Bank of Canada reissued a "sector perform" rating and issued a $23.00 price target on shares of Phreesia in a report on Friday, September 27th. JPMorgan Chase & Co. raised their price objective on shares of Phreesia from $27.00 to $28.00 and gave the stock an "overweight" rating in a research note on Monday, September 9th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $30.00 target price on shares of Phreesia in a report on Tuesday. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to MarketBeat.com, Phreesia has an average rating of "Moderate Buy" and a consensus target price of $29.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.